Intensification Therapy with Bortezomib-Melphalan-Prednisone Versus Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: An Intergroup, Multicenter, Phase III Study of the European Myeloma Network (EMN02/HO95 MM Trial)

Michele Cavo; Meral Beksac; Meletios A Dimopoulos; Lucia Pantani; Francesca Gay; Roman Hajek; Nicoletta Testoni; Ulf-Henrik Mellqvist; Francesca Patriarca; Vittorio Montefusco; Monica Galli; Hans Erik Johnsen; Heinz Ludwig; Sonja Zweegman; Ruth Wester; Ka Lung Wu; Christoph Driessen; Rossella Troia; Petra Cornelisse; Bronno van der Holt; Antonio Palumbo; Pieter Sonneveld

Intensification Therapy with Bortezomib-Melphalan-Prednisone Versus Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: An Intergroup, Multicenter, Phase III Study of the European Myeloma Network (EMN02/HO95 MM Trial)

Michele Cavo, Meral Beksac, Meletios A Dimopoulos, Lucia Pantani, Francesca Gay, Roman Hajek, Nicoletta Testoni, Ulf-Henrik Mellqvist, Francesca Patriarca, Vittorio Montefusco, Monica Galli, Hans Erik Johnsen, Heinz Ludwig, Sonja Zweegman, Ruth Wester, Ka Lung Wu, Christoph Driessen, Rossella Troia, Petra Cornelisse, Bronno van der HoltAntonio Palumbo, Pieter Sonneveld

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	673
Journal	Blood
Volume	128
Issue number	22
Number of pages	1
ISSN	0006-4971
Publication status	Published - 1 Dec 2016
Event	58th ASH Annual Meeting and Exposition - San Diego Convention Center, Hall GH, San Diego, United States Duration: 3 Dec 2016 → 6 Dec 2016 Conference number: 58 https://ash.confex.com/ash/2016/webprogram/start.html

Conference

Conference	58th ASH Annual Meeting and Exposition
Number	58
Location	San Diego Convention Center, Hall GH
Country/Territory	United States
City	San Diego
Period	03/12/2016 → 06/12/2016
Internet address	https://ash.confex.com/ash/2016/webprogram/start.html

Access to Document

http://www.bloodjournal.org/content/128/22/673.abstract

Cite this

Cavo, M., Beksac, M., Dimopoulos, M. A., Pantani, L., Gay, F., Hajek, R., Testoni, N., Mellqvist, U-H., Patriarca, F., Montefusco, V., Galli, M., Johnsen, H. E., Ludwig, H., Zweegman, S., Wester, R., Wu, K. L., Driessen, C., Troia, R., Cornelisse, P., ... Sonneveld, P. (2016). Intensification Therapy with Bortezomib-Melphalan-Prednisone Versus Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: An Intergroup, Multicenter, Phase III Study of the European Myeloma Network (EMN02/HO95 MM Trial). Blood, 128(22), [673]. http://www.bloodjournal.org/content/128/22/673.abstract

@article{a22b04d826504787a0363efc06e9b65f,

title = "Intensification Therapy with Bortezomib-Melphalan-Prednisone Versus Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: An Intergroup, Multicenter, Phase III Study of the European Myeloma Network (EMN02/HO95 MM Trial)",

author = "Michele Cavo and Meral Beksac and Dimopoulos, {Meletios A} and Lucia Pantani and Francesca Gay and Roman Hajek and Nicoletta Testoni and Ulf-Henrik Mellqvist and Francesca Patriarca and Vittorio Montefusco and Monica Galli and Johnsen, {Hans Erik} and Heinz Ludwig and Sonja Zweegman and Ruth Wester and Wu, {Ka Lung} and Christoph Driessen and Rossella Troia and Petra Cornelisse and {van der Holt}, Bronno and Antonio Palumbo and Pieter Sonneveld",

year = "2016",

month = dec,

day = "1",

language = "English",

volume = "128",

journal = "Blood",

issn = "0006-4971",

publisher = "AMER SOC HEMATOLOGY",

number = "22",

note = "58th ASH Annual Meeting and Exposition , ASH 2016 ; Conference date: 03-12-2016 Through 06-12-2016",

url = "https://ash.confex.com/ash/2016/webprogram/start.html",

}

Cavo, M, Beksac, M, Dimopoulos, MA, Pantani, L, Gay, F, Hajek, R, Testoni, N, Mellqvist, U-H, Patriarca, F, Montefusco, V, Galli, M, Johnsen, HE, Ludwig, H, Zweegman, S, Wester, R, Wu, KL, Driessen, C, Troia, R, Cornelisse, P, van der Holt, B, Palumbo, A & Sonneveld, P 2016, 'Intensification Therapy with Bortezomib-Melphalan-Prednisone Versus Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: An Intergroup, Multicenter, Phase III Study of the European Myeloma Network (EMN02/HO95 MM Trial)', Blood, vol. 128, no. 22, 673. <http://www.bloodjournal.org/content/128/22/673.abstract>

Intensification Therapy with Bortezomib-Melphalan-Prednisone Versus Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma : An Intergroup, Multicenter, Phase III Study of the European Myeloma Network (EMN02/HO95 MM Trial). / Cavo, Michele; Beksac, Meral; Dimopoulos, Meletios A et al.

In: Blood, Vol. 128, No. 22, 673, 01.12.2016.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Intensification Therapy with Bortezomib-Melphalan-Prednisone Versus Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma

T2 - 58th ASH Annual Meeting and Exposition

AU - Cavo, Michele

AU - Beksac, Meral

AU - Dimopoulos, Meletios A

AU - Pantani, Lucia

AU - Gay, Francesca

AU - Hajek, Roman

AU - Testoni, Nicoletta

AU - Mellqvist, Ulf-Henrik

AU - Patriarca, Francesca

AU - Montefusco, Vittorio

AU - Galli, Monica

AU - Johnsen, Hans Erik

AU - Ludwig, Heinz

AU - Zweegman, Sonja

AU - Wester, Ruth

AU - Wu, Ka Lung

AU - Driessen, Christoph

AU - Troia, Rossella

AU - Cornelisse, Petra

AU - van der Holt, Bronno

AU - Palumbo, Antonio

AU - Sonneveld, Pieter

N1 - Conference code: 58

PY - 2016/12/1

Y1 - 2016/12/1

M3 - Conference abstract in journal

VL - 128

JO - Blood

JF - Blood

SN - 0006-4971

IS - 22

M1 - 673

Y2 - 3 December 2016 through 6 December 2016

ER -